Showing results (21-30 of 176) with videos related to
Sort By:
Pageof 18
Cancer|February 3, 2026
Targeting HIF-2α in renal cell carcinoma: Expanding upon belzutifanMelanie Rodriguez, Qian Qin, Uttam K Tambar, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Personalized Management of Advanced Kidney CancerJeffrey Graham, Daniel Y C Heng, James Brugarolas, et al.Cancer Research|July 9, 2013
Cooperation and antagonism among cancer genes: the renal cancer paradigmSamuel Peña-Llopis, Alana Christie, Xian-Jin Xie, et al.Journal of Neuro-Oncology|November 16, 2010
mTORC1 activation in childhood ependymoma and response to sirolimusDaniel C Bowers, Blanka Kucejova, Linda Margraf, et al.World Neurosurgery|June 17, 2019
Inflammatory Reaction Secondary to Immune Checkpoint Inhibitor Therapy Mimicking a Post-Operative Brain AbscessAnkur R Patel, Scott Connors, Zabi Wardak, et al.Cancers|May 14, 2025
Systemic Treatment of Locally Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaJoseph Vento, Tian Zhang, Payal Kapur, et al.Arxiv|December 23, 2024
A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome predictionMeixu Chen, Kai Wang, Payal Kapur, et al.Autophagy|January 6, 2017
Multistep regulation of TFEB by MTORC1Silvia Vega-Rubin-de-Celis, Samuel Peña-Llopis, Meghan Konda, et al.Journal of Kidney Cancer and VHL|June 10, 2026
Pathologic Complete Response After Preoperative Ipilimumab and Nivolumab in an HLRCC Patient with Stage III Renal Cell CarcinomaNeil Rakheja, Payal Kapur, John Zimmerman, et al.Clinical Genitourinary Cancer|June 11, 2026
Nonsmall Cell Lung Cancer in Metastatic Renal Cell Carcinoma PatientsJake N Lichterman, Matthew Lee, Alana Christie, et al.Pageof 18